Showing 596 news articles about New & experimental HIV treatments

Filters Content type: News Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

The search for a cure

The cure

News
3 December 2009
New & experimental HIV treatments

New hepatitis C protease inhibitors achieve 80% ‘cure’ rate in patients with genotype 1 infection

News
3 November 2009
Starting treatment

FDA committee recommends approval of maraviroc for first-line treatment in US

News
9 October 2009
New & experimental HIV treatments

Dual maintenance therapy with atazanavir plus raltegravir sustains viral suppression

News
18 September 2009
New & experimental HIV treatments

Maturation inhibitor bevirimat is well tolerated and effective in predicted responders

News
18 September 2009
New & experimental HIV treatments

GSK's second integrase inhibitor looks potent and well-tolerated in early study

News
17 September 2009
New & experimental HIV treatments

Nutritional formula linked to reduced CD4 cell loss in untreated people

News
17 September 2009
New & experimental HIV treatments

IL-7 may boost CD4 and CD8 T-cells, study shows

News
17 September 2009
Hepatitis C treatment

Genetic test predicts who will respond to hepatitis C treatment

News
17 August 2009
Infant feeding

Triple-drug treatment during pregnancy reduces risk of nevirapine resistance

News
13 August 2009
Starting treatment

Abacavir as potent as tenofovir for patients starting HIV treatment with a high viral load

News
6 August 2009
New & experimental HIV treatments

Raltegravir moves closer to approval for first-line use in Europe

News
27 July 2009
New & experimental HIV treatments

Experimental integrase inhibitor GSK-572 looks good in early studies

News
22 July 2009
New & experimental HIV treatments

Once-daily Kaletra as safe and effective as twice-daily dosing

News
22 July 2009
TB treatment

TB Alliance, Tibotec, form partnership to take forward new drug

News
17 June 2009
New & experimental HIV treatments

New hepatitis C drug may halve the length of treatment, but ribavirin still needed

News
12 June 2009
TB transmission & prevention

New drug for MDR-TB does well in trial

News
9 June 2009
The search for a cure

`Shock and kill` approach awakens latent HIV in test tube

News
5 June 2009
New & experimental HIV treatments

Glaxo to test rival's protease inhibitor, re-engineered to last longer

News
2 June 2009
Transmission & prevention

Raltegravir shows potential for use as PrEP drug

News
28 April 2009
Pharmaceutical industry

GSK and Pfizer HIV divisions to form new company

News
17 April 2009
Drug-resistant TB

Breakthrough in XDR-TB research could lead to two-drug treatment

News
26 February 2009
New & experimental HIV treatments

Two novel ‘enhancer’ drugs boost protease inhibitors as much as ritonavir

News
10 February 2009
New & experimental HIV treatments

Panacos sells its first-in-class maturation inhibitor

News
22 January 2009